Colistin-associated acute renal failure: Revisited [8]

Southern Medical Journal

Volumn 98, Issue 12, 2005, Pages 1229-1230

  Li, Jian ^a   Rayner, Craig R ^a   Nation, Roger L ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

COLISTIMETHATE; COLISTIN; GENTAMICIN; IMIPENEM;

ADULT; ANTIBACTERIAL ACTIVITY; BACTERIAL INFECTION; CASE REPORT; CREATININE CLEARANCE; GRAM NEGATIVE BACTERIUM; HUMAN; HYPOTENSION; KIDNEY FAILURE; KIDNEY FUNCTION; LETTER; MALE; MULTIDRUG RESISTANCE; SALVAGE THERAPY;

ANTI-BACTERIAL AGENTS; COLISTIN; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INFUSIONS, INTRAVENOUS; KIDNEY FAILURE, ACUTE;

EID: 30344488110     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.smj.0000189912.79366.18     Document Type: Letter

References (12)

1. Daram SR, Gogia S, Bastani B. Colistin-associated acute renal failure: revisited. South Med J 2005;98:257-258.
2. Conway SP, Etherington C, Munday J, et al. Safety and tolerability of bolus intravenous colistin in acute respiratory exacerbations ill adults with cystic fibrosis. Ann Pharmacother 2000;34:1238-1242.
3. Li J, Coulthard K, Milne R, et al. Steady-state pharmacokinetics of intravenous colistin methanesulphonate in patients with cystic fibrosis. J. Antimicrob. Chemother 2003;52:987-992.
4. Al-Aloul M, Miller H, Alapati S, et al. Renal impairment in cystic fibrosis patients due to repeated intravenous aminoglycoside use. Pediatr Pulmonol 2005;39:15-20.
5. Falagas ME, Rizos M, Bliziotis IA, et al. Toxicity after prolonged (more than four weeks) administration of intravenous colistin. BMC Infect Dis 2005;5:1.
6. Li J, Nation RL, Milne RW, et al. Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria. Int J Antimicrob Agents 2005;25:11-25.
7. Li J, Milne RW, Nation RL, et al. Pharmacokinetics of colistin methanesulphonate and colistin in rats following an intravenous dose of colistin methanesulphonate. J Antimicrob Chemother 2004;53:837-840.
8. Li J, Turnidge J, Milne R, et al. In vitro pharmacodynamic properties of colistin and colistin methanesulfonate against Pseudomonas aeruginosa isolates from patients with cystic fibrosis. Antimicrob Agents Chemother 2001;45:781-785.
9. Li J, Milne RW, Nation RL, et al. Use of high-performance liquid chromatography to study the pharmacokinetics of colistin sulfate in rats following intravenous administration. Antimicrob Agents Chemother 2003;47:1766-1770.
10. Barnett M, Bushby SR, Wilkinson S. Sodium sulphomethyl derivatives of polymyxins. Br J Pharmacol 1964;23:552-574.
11. Li J, Milne RW, Nation RL, et al. A simple method for the assay of colistin in human plasma, using pre-column derivatization with 9-fluorenylmethyl chloroformate in solid-phase extraction cartridges and reversed-phase high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl 2001;761:167-175.
12. Li J, Milne RW, Nation RL, et al. Simple method for assaying colistin methanesulfonate in plasma and urine using high-performance liquid chromatography. Antimicrob Agents Chemother 2002;46:3304-3307.